Subscribe
Funding & M&A
5 min read

A Top-Three Global Pet Care Player Just Bought Its Way Into Brazil

Unicharm announced on May 15 that it will acquire 100% of Brazilian premium pet food maker Nutrire, marking its full-scale entry into the world's third-largest pet care market. The deal is the first move under Unicharm's 2026-2030 mid-term plan and the operational start of a multi-year LatAm pet consolidation cycle that strategic buyers have been previewing for two years.

Written by
The Underbite
Published on
May 22, 2026
A Top-Three Global Pet Care Player Just Bought Its Way Into Brazil

The world's third-largest pet care market — and the fastest-growing of the three — now has a new strategic owner with $7 billion in annual revenue behind it. Unicharm announced on May 15 it will acquire 100% of Brazilian premium pet food maker Nutrire, marking its full-scale entry into a market growing more than 10% annually. The deal signals the start of a strategic-buyer scramble for LatAm pet assets that has been long expected and is now operative.

Unicharm acquires 100% of Nutrire to enter Brazil pet care

Unicharm Corporation (TOKYO: 8113) announced on May 15, 2026 a definitive agreement to acquire 100% of Nutrire Indústria de Alimentos Ltda., a São Paulo-state premium pet food manufacturer. Financial terms were not disclosed. The transaction is subject to Brazilian regulatory approval and standard closing conditions; Unicharm did not specify a completion date.

Nutrire, founded in 2001, operates the full pet-food value chain: raw-material selection, formulation, manufacturing, and sales. The company is known for premium dry food and exports to neighboring Central and South American markets. Unicharm framed the asset's value as Nutrire's "high-quality production base and extensive export network."

For Unicharm, this is the first major M&A step under its 13th Mid-Term Management Plan, "Project-Renaissance" (2026–2030), which formally designates wellness and pet care as the company's growth priorities for the back half of the decade. Unicharm has run a pet care business since 1986 and operates in more than 80 countries, but Brazil is the largest market in which it has not had on-the-ground manufacturing.

Brazil is the world's third-largest pet care market behind the U.S. and China. The pet food segment alone was valued at roughly $10 billion in 2025, and the broader Brazilian pet sector was forecast to reach R$78 billion (~$13.3 billion) in 2025 revenue. Forward growth projections range widely depending on the source: GlobalPETS reported a modest 3.5% rise expected in 2025, while Mordor Intelligence forecasts a 7-8% CAGR through 2030 and Unicharm itself cites "over 10% annually" in its announcement. Pet humanization, premium-segment growth, and a long-running shortage of domestic premium-pet-food manufacturing capacity have made the market the most attractive on the continent for a multi-year hold.

Why this is the first move in a LatAm pet M&A cycle, not a one-off

Most analysis of this deal will frame it as Unicharm catching up to Mars and Nestlé Purina in Brazil. That reading is too narrow. What the Nutrire acquisition actually signals is the operational start of a multi-year LatAm pet consolidation cycle that strategic buyers have been previewing in earnings calls for two years.

Three forces converge to make Brazil and adjacent markets the next strategic-buyer focus.

1. The premium-food capacity gap is real and durable. Brazil's pet population is one of the largest in the world, but a disproportionate share of its premium and super-premium volume is imported from the U.S. and Argentina. Local manufacturing capacity for high-end extruded and freeze-dried product is constrained. A buyer acquiring Nutrire is buying production capacity that cannot be replicated in 24 months by greenfield investment. The same dynamic applies in Mexico and Colombia.

2. The strategic-buyer pool just expanded beyond the obvious names. Mars, Nestlé Purina, and Colgate-Palmolive's Hill's already have Brazilian footprints. Unicharm entering at scale signals that the second tier of global pet-care players — General Mills (Blue Buffalo), Post Holdings (Perfection Pet Foods), Inaba, and the Japanese and Korean pet-care majors — now treat LatAm as required, not optional. Each of those companies has a similar gap to close, and most have stronger balance sheets in 2026 than they had in 2023.

3. Pet-humanization economics finally support premium pricing across the region. Brazil's per-capita pet spend remains below U.S. and European benchmarks, but the gradient is steep and tracking premium-food growth in real time. The same trend is visible, with lag, in Mexico, Colombia, Chile, and Peru. A strategic buying Nutrire today is paying a multiple based on 2030 premium-segment penetration, not 2025 baseline volume. That gap closes faster than incumbent strategics modeled three years ago.

The competitive read for operators inside LatAm pet markets is concrete. Local premium-positioned manufacturers — Adimax, Premier Pet, BRF (via the Guabi line), GranPlus — are now sitting on assets a global strategic will pay a meaningful premium for. Founders who delayed inbound conversations through 2024-2025 expecting a better cycle should reassess. The cycle is here, and it is being run by buyers with declared mandates, not opportunists.

The read for U.S.-headquartered pet brands is harder. Brazil's premium-food shelf is filling fast, and the manufacturing capacity that supplies private-label and contract-pack work is being consolidated by acquirers who plan to use it for owned brands. Window for partnership-based market entry is narrowing.

A note on what Unicharm did not buy: Nutrire's export network is a real but constrained asset. Production is concentrated, and serving an expanding LatAm footprint will require either capacity expansion or follow-on M&A in adjacent markets. That sets up a second Unicharm transaction inside this cycle.

What to watch through 2026

Regulatory timeline. Brazil's CADE (Administrative Council for Economic Defense) will review the transaction. Most strategic foreign-acquirer pet-food deals clear without conditions, but with Mars, Nestlé Purina, and Hill's already operating significant local capacity, this is the first deal in which a fourth global premium player crosses the threshold. Watch for any market-share remedies attached to clearance.

The next two Unicharm announcements. Project-Renaissance runs through 2030. Nutrire is one node in a multi-acquisition plan. The next two moves — likely in pet-snack/treat manufacturing and possibly a Mexican or Colombian capacity asset — will reveal the broader regional thesis. Earnings calls in August and November are the right read.

Response from Mars and Nestlé Purina. Both incumbents have been quiet on LatAm M&A through 2025. A premium-segment competitor with $7B of global revenue and a declared pet-care mandate changes that calculus. Watch for either bolt-on acquisitions of premium local brands (the most likely move) or capacity expansions through 2026.

Strategic-buyer pricing in the region. Premium-pet-food multiples paid in LatAm in 2024-2025 ran below U.S. comps. The Nutrire deal, if its undisclosed price proves consistent with strategic-buyer comps elsewhere, will reset that anchor. Bankers running LatAm pet processes through year-end should expect upward revisions.

Source: Unicharm announcement via Business Wire

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
The Farmer's Dog buys two years of Oprah, and fresh pet food enters its share-defense era
Strategy
5 min read

The Farmer's Dog buys two years of Oprah, and fresh pet food enters its share-defense era

The Farmer's Dog announced a two-year partnership with The Oprah Podcast today, including a Winfrey-narrated mini-series and sponsored episodes. At $1.2B in annualized revenue and an estimated $4.2B valuation, the deal signals fresh pet food has entered its category-defense phase — with implications for Freshpet, the post-acquisition Ollie, and the next DTC raise.

Read article
Read article
A Human-Medical Distribution Giant Just Crossed Into the Vet Channel
Strategy
5 min read

A Human-Medical Distribution Giant Just Crossed Into the Vet Channel

Medline, the nation's largest medical-surgical distributor and a 45,000-employee, 100-country company, formally entered animal-health distribution on May 20 with custom spay/neuter surgical packs for shelters and high-volume spay/neuter clinics. The shelter beachhead is strategically smart: it is the least-defended segment of the vet supply channel. The bigger story is the kitting capability, which is how human procedural medicine transformed turnover, and which Medline running into animal health is a structural threat to Patterson Veterinary, Henry Schein Animal Health, and Covetrus.

Read article
Read article
The Independent Vet Defense Finally Has Numbers
Strategy
5 min read

The Independent Vet Defense Finally Has Numbers

Covetrus announced VetSuite has crossed 4,000 independent member practices nationwide, with $150M in cumulative member benefits, $30K average annual savings per practice, and 27% more online pharmacy revenue per DVM than non-participating independents. The disclosed economics are the strongest "stay independent" case a buying group has made against the decade-long corporate consolidation wave from Mars, JAB-backed NVA, and PE-backed roll-ups. VetSuite is at roughly 13% of the estimated 30,000+ U.S. companion-animal clinic market, approaching the 15-20% plateau zone buying groups in adjacent human-medical verticals historically hit.

Read article
View all articles